267 related articles for article (PubMed ID: 24519603)
1. Valuation of EQ-5D-3L health states in Singapore: modeling of time trade-off values for 80 empirically observed health states.
Luo N; Wang P; Thumboo J; Lim YW; Vrijhoef HJ
Pharmacoeconomics; 2014 May; 32(5):495-507. PubMed ID: 24519603
[TBL] [Abstract][Full Text] [Related]
2. Chinese time trade-off values for EQ-5D health states.
Liu GG; Wu H; Li M; Gao C; Luo N
Value Health; 2014 Jul; 17(5):597-604. PubMed ID: 25128053
[TBL] [Abstract][Full Text] [Related]
3. Estimating an EQ-5D-Y-3L Value Set for Indonesia by Mapping the DCE onto TTO Values.
Fitriana TS; Roudijk B; Purba FD; Busschbach JJV; Stolk E
Pharmacoeconomics; 2022 Dec; 40(Suppl 2):157-167. PubMed ID: 36348155
[TBL] [Abstract][Full Text] [Related]
4. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
[TBL] [Abstract][Full Text] [Related]
5. Does diabetes have an impact on health-state utility? a study of Asians in Singapore.
Wang P; Tai ES; Thumboo J; Vrijhoef HJ; Luo N
Patient; 2014; 7(3):329-37. PubMed ID: 24756482
[TBL] [Abstract][Full Text] [Related]
6. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
[TBL] [Abstract][Full Text] [Related]
7. Do Chinese have similar health-state preferences? A comparison of mainland Chinese and Singaporean Chinese.
Wang P; Li MH; Liu GG; Thumboo J; Luo N
Eur J Health Econ; 2015 Nov; 16(8):857-63. PubMed ID: 25260384
[TBL] [Abstract][Full Text] [Related]
8. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states.
Lee YK; Nam HS; Chuang LH; Kim KY; Yang HK; Kwon IS; Kind P; Kweon SS; Kim YT
Value Health; 2009; 12(8):1187-93. PubMed ID: 19659703
[TBL] [Abstract][Full Text] [Related]
9. Valuation of Quality Weights for EuroQol 5-Dimensional Health States With the Time Trade-Off Method in the Capital of Iran.
Goudarzi R; Sari AA; Zeraati H; Rashidian A; Mohammad K; Amini S
Value Health Reg Issues; 2019 May; 18():170-175. PubMed ID: 31096140
[TBL] [Abstract][Full Text] [Related]
10. Similar responses to EQ-5D-3L by two elicitation methods: visual analogue scale and time trade-off.
Wang X; Zhuo L; Ma Y; Cai T; Must A; Xu L; Zhuo L
BMC Med Res Methodol; 2020 May; 20(1):118. PubMed ID: 32410582
[TBL] [Abstract][Full Text] [Related]
11. Time Trade-Off Value Set for EQ-5D-3L Based on a Nationally Representative Chinese Population Survey.
Zhuo L; Xu L; Ye J; Sun S; Zhang Y; Burstrom K; Chen J
Value Health; 2018 Nov; 21(11):1330-1337. PubMed ID: 30442281
[TBL] [Abstract][Full Text] [Related]
12. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
[TBL] [Abstract][Full Text] [Related]
13. Valuing health-related quality of life using a hybrid approach: Tunisian value set for the EQ-5D-3L.
Chemli J; Drira C; Felfel H; Roudijk B; Al Sayah F; Kouki M; Kooli A; Razgallah Khrouf M
Qual Life Res; 2021 May; 30(5):1445-1455. PubMed ID: 33447958
[TBL] [Abstract][Full Text] [Related]
14. Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan.
Lee HY; Hung MC; Hu FC; Chang YY; Hsieh CL; Wang JD
J Formos Med Assoc; 2013 Nov; 112(11):699-706. PubMed ID: 24183199
[TBL] [Abstract][Full Text] [Related]
15. Estimating an EQ-5D-3L Value Set for Romania Using Time Trade-Off.
Paveliu MS; Olariu E; Caplescu R; Oluboyede Y; Niculescu-Aron IG; Ernu S; Vale L
Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299864
[TBL] [Abstract][Full Text] [Related]
16. In search of a 'pan-European value set'; application for EQ-5D-3L.
Sajjad A; Versteegh MM; Santi I; Busschbach J; Simon J; Roijen LH
BMC Med Res Methodol; 2023 Jan; 23(1):13. PubMed ID: 36635625
[TBL] [Abstract][Full Text] [Related]
17. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
[TBL] [Abstract][Full Text] [Related]
18. Estimating an exchange rate between the EQ-5D-3L and ASCOT.
Stevens K; Brazier J; Rowen D
Eur J Health Econ; 2018 Jun; 19(5):653-661. PubMed ID: 28623464
[TBL] [Abstract][Full Text] [Related]
19. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
[TBL] [Abstract][Full Text] [Related]
20. An experience- and preference-based EQ-5D-3L value set derived using 18 months of longitudinal data in patients who sustained a fracture: results from the ICUROS.
Svedbom A; Borgstöm F; Hernlund E; Alekna V; Bianchi ML; Clark P; Diaz-Curiel M; Dimai HP; Jürisson M; Lesnyak O; McCloskey E; Sanders KM; Silverman S; Tamulaitiene M; Thomas T; Tosteson ANA; Jönsson B; Kanis JA
Qual Life Res; 2023 Apr; 32(4):1199-1208. PubMed ID: 36495384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
